ATE325878T1 - Verfahren zur herstellung von optisch aktiven verbindungen - Google Patents

Verfahren zur herstellung von optisch aktiven verbindungen

Info

Publication number
ATE325878T1
ATE325878T1 AT98110546T AT98110546T ATE325878T1 AT E325878 T1 ATE325878 T1 AT E325878T1 AT 98110546 T AT98110546 T AT 98110546T AT 98110546 T AT98110546 T AT 98110546T AT E325878 T1 ATE325878 T1 AT E325878T1
Authority
AT
Austria
Prior art keywords
hydroxy
producing
optically active
active connections
producing optically
Prior art date
Application number
AT98110546T
Other languages
English (en)
Inventor
Shin-Ichi Hashimoto
Ryoichi Katsumata
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15507139&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE325878(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of ATE325878T1 publication Critical patent/ATE325878T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/347Saturated compounds containing more than one carboxyl group containing keto groups
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/77Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/44Polycarboxylic acids
    • C12P7/46Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98110546T 1997-06-09 1998-06-09 Verfahren zur herstellung von optisch aktiven verbindungen ATE325878T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15091397 1997-06-09

Publications (1)

Publication Number Publication Date
ATE325878T1 true ATE325878T1 (de) 2006-06-15

Family

ID=15507139

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98110546T ATE325878T1 (de) 1997-06-09 1998-06-09 Verfahren zur herstellung von optisch aktiven verbindungen

Country Status (7)

Country Link
US (2) US6207427B1 (de)
EP (1) EP0884390B1 (de)
KR (1) KR100511734B1 (de)
CN (2) CN1084388C (de)
AT (1) ATE325878T1 (de)
CA (2) CA2234412C (de)
DE (1) DE69834452T2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297800B2 (en) * 2001-12-27 2007-11-20 Ajinomoto Co., Inc. Process of producing glutamate derivatives
CN100549182C (zh) * 2001-12-27 2009-10-14 味之素株式会社 谷氨酸衍生物的制备方法
US8372989B2 (en) 2002-04-23 2013-02-12 Cargill, Incorporated Polypeptides and biosynthetic pathways for the production of monatin and its precursors
PL208481B1 (pl) * 2002-04-23 2011-05-31 Cargill Sposób wytwarzania monatyny
US7572607B2 (en) * 2002-04-23 2009-08-11 Cargill, Incorporated Polypeptides and biosynthetic pathways for the production of monatin and its precursors
RU2307871C2 (ru) 2002-08-26 2007-10-10 Адзиномото Ко., Инк. НОВАЯ АЛЬДОЛАЗА И СПОСОБ ПОЛУЧЕНИЯ ЗАМЕЩЕННЫХ α-КЕТОКИСЛОТ
AU2003289264A1 (en) 2002-12-09 2004-06-30 Ajinomoto Co., Inc. Mutant d-aminotransferase and process for producing optically active glutamic acid derivative using the same
WO2005014839A2 (en) * 2003-08-01 2005-02-17 Cargill, Incorporated Monatin tabletop sweetener compositions and methods of making same
WO2005020721A1 (en) * 2003-08-25 2005-03-10 Cargill, Incorporated Beverage compositions comprising monatin and methods of making same
EP1678313B1 (de) * 2003-10-21 2011-02-16 Cargill, Incorporated Herstellung von monatin und monatinvorstufen
US7180370B2 (en) * 2004-09-01 2007-02-20 Micron Technology, Inc. CMOS amplifiers with frequency compensating capacitors
US8153405B2 (en) * 2005-04-20 2012-04-10 Cargill, Incorporated Products and methods for in vivo secretion of monatin
US8158389B2 (en) * 2005-04-20 2012-04-17 Cargill, Incorporated Products and methods for in vivo secretion of monatin
US7582455B2 (en) * 2005-04-26 2009-09-01 Cargill, Incorporated Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors
US8076108B2 (en) 2005-04-26 2011-12-13 Cargill, Incorporated Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors
MX2008011477A (es) * 2006-03-07 2008-09-23 Cargill Inc Aldolasas, acidos nucleicos que las codifican y metodos para hacerlas y usarlas.
KR100846676B1 (ko) * 2006-04-27 2008-07-16 엔자이텍 주식회사 효소적 방법에 의한 광학활성 2-할로-2-(엔-치환된페닐)아세트산 에스테르와 2-할로-2-(엔-치환된페닐)아세트산의 제조 방법
US8647642B2 (en) 2008-09-18 2014-02-11 Aviex Technologies, Llc Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57183799A (en) 1981-04-17 1982-11-12 Kyowa Hakko Kogyo Co Ltd Novel plasmid
JPS5911188A (ja) * 1982-07-12 1984-01-20 Mitsubishi Gas Chem Co Inc D−グルコサミン酸の製造法
JPS63218621A (ja) 1987-03-09 1988-09-12 Kazuoki Tsuchiya 肥満症の予防・治療用組成物
JP2578488B2 (ja) * 1988-03-04 1997-02-05 協和醗酵工業株式会社 アミノ酸の製造法
US5218092A (en) 1988-09-29 1993-06-08 Kyowa Hakko Kogyo Co., Ltd. Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains
IL98312A0 (en) * 1990-06-04 1992-06-21 Univ Notre Dame Du Lac Process for preparation of beta-hydroxy-alpha-amino acids
EP0555475B1 (de) * 1991-08-26 1997-05-14 Kyowa Hakko Kogyo Co., Ltd. Verfahren zur herstellung von 4-hydroxy-l-prolin
JP3005086B2 (ja) 1991-10-23 2000-01-31 三共株式会社 シス−4−ヒドロキシ−l−プロリンの製造法
JP3151075B2 (ja) 1992-12-22 2001-04-03 協和醗酵工業株式会社 アラニンの製造法
KR100356926B1 (ko) * 1993-09-07 2003-01-10 교와 핫꼬 고교 가부시끼가이샤 트랜스-4-히드록시-l-프롤린의제조법
JP3698742B2 (ja) * 1994-03-01 2005-09-21 協和醗酵工業株式会社 光学活性4−ヒドロキシ−2−ケトグルタル酸の製造法
EP0692539B1 (de) 1994-07-11 1999-09-22 Kyowa Hakko Kogyo Co., Ltd. Verfahren zur Herstellung von optisch aktiver Gamma-hydroxy-L-Glutaminsäure

Also Published As

Publication number Publication date
EP0884390A2 (de) 1998-12-16
CA2234412C (en) 2008-09-02
KR19990006810A (ko) 1999-01-25
US20020006645A1 (en) 2002-01-17
CN1381586A (zh) 2002-11-27
CN1214366A (zh) 1999-04-21
HK1019460A1 (en) 2000-02-11
CA2234412A1 (en) 1998-12-09
DE69834452T2 (de) 2007-05-10
CA2633357A1 (en) 1998-12-09
CN1084388C (zh) 2002-05-08
US6207427B1 (en) 2001-03-27
DE69834452D1 (de) 2006-06-14
EP0884390A3 (de) 2003-10-08
EP0884390B1 (de) 2006-05-10
KR100511734B1 (ko) 2005-10-24
US6365381B2 (en) 2002-04-02

Similar Documents

Publication Publication Date Title
ATE325878T1 (de) Verfahren zur herstellung von optisch aktiven verbindungen
BR9508022A (pt) Bactéria corineforme produtora de ácido l-glutâmico, processo para produzir ácido l-glutâmico, gene codificando para uma enzima, dna recombinante, bactéria corineforme, e, processo para produzir l-lisina
DK0691405T3 (da) Materialer og fremgangsmåde til hypersecernering af aminosyrer
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
DE69940623D1 (de) Prozess zur Synthetisierung von Nukleinsäure
DK0748382T3 (da) Enzymatisk nukleinsyre indeholdende ikke-nukleotid
NO20013801D0 (no) Ny karbonyl reduktase, gen derav og metode for anvendelse av det samme
EE05008B1 (et) Meetod kiraalsete karboksüülhapete saamiseks nitriilidest nitrilaasi v?i mikroorganismide abil, missisaldavad ühte geeni nitrilaasi jaoks
EP1365025A4 (de) Agarase und gen dafür
AU5720498A (en) Chemical synthesis of nucleosides analogs and their incorporation into polynucleotides
ATE409235T1 (de) Verfahren zur herstellung von ascorbinsäurezwischenprodukten in wirtszellen
AU2724895A (en) Nucleic acid sequence encoding trypsin-like enzyme and process for producing the enzyme
DE69632643T2 (de) Verwendungen von nukleinsäuren die ein retrovirus aus schweinen entnommen sind
ATE341640T1 (de) Verfahren zur herstellung von nicht-proteinogenen l-aminosäuren
ATE475646T1 (de) Verfahren zur herstellung von pyrrolidonen
EP1188826A3 (de) 5-substituerte Hydantoin Racemase, dafür kodierende DNA, und Verfahren zur Herstellung optisch aktiver Aminosäure
AU5727099A (en) A 2,6-beta-d-fructan hydrolase enzyme and processes for using the enzyme
ATE271561T1 (de) Verfahren zur herstellung von einer amid verbindung
IT1223330B (it) Processo per la sintesi di una n n dialchil idrossilammina
ATE235461T1 (de) Verfahren zur herstellung von 3-cyano-2,4- dihalogen-5-fluor-benzoesäuren
DE69621714D1 (de) Verfahren zur herstellung von trans-4-hydroxy-l-prolin
AU2001276385A1 (en) Nucleotide sequences which code for the lysr3 gene
KR970702920A (ko) 시스-3-히드록시-엘-프롤린의 제조법(process for producing cis-3- hydroxy-l-proline)
IL142680A0 (en) Minimal promoters and uses thereof
IL142664A0 (en) Prv-1 gene, processes for detecting the prv-1 polypeptide and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties